Marine natural products as targeted modulators of the transcription factor NF-kappa B

Florence Folmer, Marcel Jaspars, Mario Dicato, Marc Diederich

Research output: Contribution to journalEditorial

71 Citations (Scopus)

Abstract

The inducible transcription factor nuclear factor-kappaB (NF-kappa B) plays an important role in the regulation of immune, inflammatory and carcinogenic responses. While normal NF-kappa B activation is necessary for cell survival and immunity, deregulated NF-kappa B expression is a characteristic phenomenon in cancer development, as well as in several inflammatory diseases. Hence, NF-kappa B has become a major target in drug discovery, and several natural and synthetic compounds have been investigated for their potential to inhibit NF-kappa B. Here, we discuss the applications of marine natural products, in particular, as novel, potent NF-kappa B inhibitors. With the oceans covering two-thirds of the Earth's surface, and with the uniqueness of the environmental properties of marine habitats, it is easily understandable that organisms thriving in the oceans constitute a rich source of chemically unique and biomedically powerful secondary metabolites. Since the early 1960s, significant effort has been placed on the pharmacological evaluation of marine secondary metabolites. Noteworthy achievements of this field of biomedically guided marine exploration, a scientific endeavour often referred to as the search for "Drugs from the Sea", include the discovery of numerous potent anti-cancer, anti-inflammatory, antimicrobial, and analgesic compounds. The chemical characteristics and molecular targets of marine NF-kappa B inhibitors discovered to date are presented and discussed in the context of marine chemical ecology. (c) 2007 Elsevier Inc. All rights reserved.

Original languageEnglish
Pages (from-to)603-617
Number of pages15
JournalBiochemical Pharmacology
Volume75
Issue number3
Early online date7 Aug 2007
DOIs
Publication statusPublished - 1 Feb 2008

Keywords

  • NF-kappaB
  • natural product
  • marine compounds
  • cell signalling
  • drug discovery
  • secretory phospholipase A(2)
  • ubiquitin-activating enzyme
  • necrosis-factor-alpha
  • proteasome inhibitor
  • cancer-therapy
  • sesquiterpene lactones
  • DNA-binding
  • pathway
  • cells

Cite this

Marine natural products as targeted modulators of the transcription factor NF-kappa B. / Folmer, Florence; Jaspars, Marcel; Dicato, Mario; Diederich, Marc.

In: Biochemical Pharmacology, Vol. 75, No. 3, 01.02.2008, p. 603-617.

Research output: Contribution to journalEditorial

Folmer, Florence ; Jaspars, Marcel ; Dicato, Mario ; Diederich, Marc. / Marine natural products as targeted modulators of the transcription factor NF-kappa B. In: Biochemical Pharmacology. 2008 ; Vol. 75, No. 3. pp. 603-617.
@article{8579a54cb64447df87a8579b94c83166,
title = "Marine natural products as targeted modulators of the transcription factor NF-kappa B",
abstract = "The inducible transcription factor nuclear factor-kappaB (NF-kappa B) plays an important role in the regulation of immune, inflammatory and carcinogenic responses. While normal NF-kappa B activation is necessary for cell survival and immunity, deregulated NF-kappa B expression is a characteristic phenomenon in cancer development, as well as in several inflammatory diseases. Hence, NF-kappa B has become a major target in drug discovery, and several natural and synthetic compounds have been investigated for their potential to inhibit NF-kappa B. Here, we discuss the applications of marine natural products, in particular, as novel, potent NF-kappa B inhibitors. With the oceans covering two-thirds of the Earth's surface, and with the uniqueness of the environmental properties of marine habitats, it is easily understandable that organisms thriving in the oceans constitute a rich source of chemically unique and biomedically powerful secondary metabolites. Since the early 1960s, significant effort has been placed on the pharmacological evaluation of marine secondary metabolites. Noteworthy achievements of this field of biomedically guided marine exploration, a scientific endeavour often referred to as the search for {"}Drugs from the Sea{"}, include the discovery of numerous potent anti-cancer, anti-inflammatory, antimicrobial, and analgesic compounds. The chemical characteristics and molecular targets of marine NF-kappa B inhibitors discovered to date are presented and discussed in the context of marine chemical ecology. (c) 2007 Elsevier Inc. All rights reserved.",
keywords = "NF-kappaB, natural product, marine compounds, cell signalling, drug discovery, secretory phospholipase A(2), ubiquitin-activating enzyme, necrosis-factor-alpha, proteasome inhibitor, cancer-therapy, sesquiterpene lactones, DNA-binding, pathway, cells",
author = "Florence Folmer and Marcel Jaspars and Mario Dicato and Marc Diederich",
year = "2008",
month = "2",
day = "1",
doi = "10.1016/j.bcp.2007.07.044",
language = "English",
volume = "75",
pages = "603--617",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Marine natural products as targeted modulators of the transcription factor NF-kappa B

AU - Folmer, Florence

AU - Jaspars, Marcel

AU - Dicato, Mario

AU - Diederich, Marc

PY - 2008/2/1

Y1 - 2008/2/1

N2 - The inducible transcription factor nuclear factor-kappaB (NF-kappa B) plays an important role in the regulation of immune, inflammatory and carcinogenic responses. While normal NF-kappa B activation is necessary for cell survival and immunity, deregulated NF-kappa B expression is a characteristic phenomenon in cancer development, as well as in several inflammatory diseases. Hence, NF-kappa B has become a major target in drug discovery, and several natural and synthetic compounds have been investigated for their potential to inhibit NF-kappa B. Here, we discuss the applications of marine natural products, in particular, as novel, potent NF-kappa B inhibitors. With the oceans covering two-thirds of the Earth's surface, and with the uniqueness of the environmental properties of marine habitats, it is easily understandable that organisms thriving in the oceans constitute a rich source of chemically unique and biomedically powerful secondary metabolites. Since the early 1960s, significant effort has been placed on the pharmacological evaluation of marine secondary metabolites. Noteworthy achievements of this field of biomedically guided marine exploration, a scientific endeavour often referred to as the search for "Drugs from the Sea", include the discovery of numerous potent anti-cancer, anti-inflammatory, antimicrobial, and analgesic compounds. The chemical characteristics and molecular targets of marine NF-kappa B inhibitors discovered to date are presented and discussed in the context of marine chemical ecology. (c) 2007 Elsevier Inc. All rights reserved.

AB - The inducible transcription factor nuclear factor-kappaB (NF-kappa B) plays an important role in the regulation of immune, inflammatory and carcinogenic responses. While normal NF-kappa B activation is necessary for cell survival and immunity, deregulated NF-kappa B expression is a characteristic phenomenon in cancer development, as well as in several inflammatory diseases. Hence, NF-kappa B has become a major target in drug discovery, and several natural and synthetic compounds have been investigated for their potential to inhibit NF-kappa B. Here, we discuss the applications of marine natural products, in particular, as novel, potent NF-kappa B inhibitors. With the oceans covering two-thirds of the Earth's surface, and with the uniqueness of the environmental properties of marine habitats, it is easily understandable that organisms thriving in the oceans constitute a rich source of chemically unique and biomedically powerful secondary metabolites. Since the early 1960s, significant effort has been placed on the pharmacological evaluation of marine secondary metabolites. Noteworthy achievements of this field of biomedically guided marine exploration, a scientific endeavour often referred to as the search for "Drugs from the Sea", include the discovery of numerous potent anti-cancer, anti-inflammatory, antimicrobial, and analgesic compounds. The chemical characteristics and molecular targets of marine NF-kappa B inhibitors discovered to date are presented and discussed in the context of marine chemical ecology. (c) 2007 Elsevier Inc. All rights reserved.

KW - NF-kappaB

KW - natural product

KW - marine compounds

KW - cell signalling

KW - drug discovery

KW - secretory phospholipase A(2)

KW - ubiquitin-activating enzyme

KW - necrosis-factor-alpha

KW - proteasome inhibitor

KW - cancer-therapy

KW - sesquiterpene lactones

KW - DNA-binding

KW - pathway

KW - cells

U2 - 10.1016/j.bcp.2007.07.044

DO - 10.1016/j.bcp.2007.07.044

M3 - Editorial

VL - 75

SP - 603

EP - 617

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 3

ER -